Company news

Oxford Nanopore Technologies PLC news in 2025

Oxford Nanopore Technologies PLC's news releases, calls and decks from 2025, newest first.

View company

AGM Post-Meeting Shareholder Engagement Update

December 8, 2025

Appointment of Francis Van Parys as CEO

December 8, 2025

Upcoming investor conferences

November 27, 2025

ONT postpones investor event; reaffirms guidance

November 7, 2025

Upcoming Investor Conferences and Events

October 16, 2025

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032

October 9, 2025

Block listing Interim Review

October 6, 2025

Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows

September 10, 2025

Interim results for the 6 months ended 30 June 25

September 2, 2025

Share Incentive Plan - Director/PDMR Notification

August 13, 2025

Chief Executive Officer Succession

August 11, 2025

Result of Audit Tender

August 8, 2025

ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology

August 7, 2025

Commencement of legal action against MGI Australia

August 6, 2025

Holding(s) in Company

July 29, 2025

Half Year Trading Update and Notice of Results

July 21, 2025

Publication of 2024 Sustainability Report

July 4, 2025

Changes in Composition of Remuneration Committee

June 5, 2025

Result of AGM

June 4, 2025

London Calling Technology Update

May 22, 2025

Founder LTIP - Director/PDMR Notification

April 30, 2025

Publication of Annual Report and Notice of AGM

April 30, 2025

Director/PDMR Shareholding - LTIP and DBP awards

April 14, 2025

Oxford Nanopore and Cepheid collaboration

April 9, 2025

SIP PDMR Notification - Correction

March 14, 2025

Annual results for the year ended 31 December 2024

March 4, 2025

SIP PDMR Notification and Correction

January 13, 2025

Presentation at 43rd Annual J.P. Morgan Conference

January 7, 2025

Decks in 2025